<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04246008</url>
  </required_header>
  <id_info>
    <org_study_id>CEI18/111</org_study_id>
    <nct_id>NCT04246008</nct_id>
  </id_info>
  <brief_title>Effects of Neuromuscular Training on Functional Capacity in Acute Coronary Syndrome Patients</brief_title>
  <official_title>Effects of Neuromuscular Training on Functional Capacity in Acute Coronary Syndrome Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardenal Herrera University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cardenal Herrera University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to analyse the effects of neuromuscular training on functional
      capacity in patients with acute coronary syndrome, compared to the classic strength training
      of the cardiac rehabilitation programs
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      So far, there are no previous studies that analyze the effects of neuromuscular training on
      functional capacity in patients with acute coronary syndrome.

      Aim: The main objective of this study is to assess the effects of a 10 weeks neuromuscular
      training vs traditional strength training programme in patients with acute coronary syndrome.

      Design: Randomized clinical trial
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">January 11, 2021</start_date>
  <completion_date type="Anticipated">July 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This is a mixed-design study. It includes a two-group parallel, randomized clinical trial with acute coronary syndrome patients.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incremental Shuttle Walking Test</measure>
    <time_frame>10 weeks</time_frame>
    <description>Maximum distance reached</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Chester Step Test</measure>
    <time_frame>10 weeks</time_frame>
    <description>Time performing the test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 seconds sit-to- stand test</measure>
    <time_frame>10 weeks</time_frame>
    <description>Number of repetitions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in hip muscle strength</measure>
    <time_frame>10 weeks</time_frame>
    <description>Measured with dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiopulmonary exercise testing</measure>
    <time_frame>10 weeks</time_frame>
    <description>METS achieved in ergometry</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>Neuromuscular training group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive a 60-min neuromuscular training sessions twice a week, for 10 weeks until the completion of twenty sessions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional training group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive a 60-min convencional cardiac rehabiliation session twice a week, for 10 weeks until the completion of twenty sessions</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neuromuscular training</intervention_name>
    <description>The exercise training was developed based on assuring the correct performance of the exercise focusing in motor control.</description>
    <arm_group_label>Neuromuscular training group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional strength training</intervention_name>
    <description>The exercise training was developed based on standard strength training used in cardiac rehabiliation programmes</description>
    <arm_group_label>Conventional training group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute coronary syndrome patients

          -  Physical activity must have been prescribed

        Exclusion Criteria:

          -  inflammatory cardiac disease

          -  severe or moderate ventricular dysfunction

          -  heart failure

          -  severe arrhytmias

          -  systemic hypertension &gt;95% percentile

          -  pulmonary hypertension &gt;40 mmHg

          -  aortic stenosis

          -  baseline O2 &lt;90%

          -  severe valve insufficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Dolores Arguisuelas</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardenal Herrera University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Dolores Arguisuelas</last_name>
    <phone>96 136 90 00</phone>
    <email>doloresarguisuelas@uchceu.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Arguisuelas Martinez Maria Dolores</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ARGUISUELAS MARTINEZ DOLORES, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet. 2001 Mar 31;357(9261):995-1001.</citation>
    <PMID>11293642</PMID>
  </reference>
  <reference>
    <citation>Skou ST, Roos EM. Good Life with osteoArthritis in Denmark (GLA:D™): evidence-based education and supervised neuromuscular exercise delivered by certified physiotherapists nationwide. BMC Musculoskelet Disord. 2017 Feb 7;18(1):72. doi: 10.1186/s12891-017-1439-y.</citation>
    <PMID>28173795</PMID>
  </reference>
  <reference>
    <citation>Thompson PD, Arena R, Riebe D, Pescatello LS; American College of Sports Medicine. ACSM's new preparticipation health screening recommendations from ACSM's guidelines for exercise testing and prescription, ninth edition. Curr Sports Med Rep. 2013 Jul-Aug;12(4):215-7. doi: 10.1249/JSR.0b013e31829a68cf.</citation>
    <PMID>23851406</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>January 27, 2020</study_first_submitted>
  <study_first_submitted_qc>January 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2020</study_first_posted>
  <last_update_submitted>July 23, 2020</last_update_submitted>
  <last_update_submitted_qc>July 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cardenal Herrera University</investigator_affiliation>
    <investigator_full_name>ARGUISUELAS MARTINEZ MARÍA DOLORES</investigator_full_name>
    <investigator_title>Head of Physiotherapy Department</investigator_title>
  </responsible_party>
  <keyword>acute coronary syndrome</keyword>
  <keyword>neuromuscular training</keyword>
  <keyword>cardiac rehabilitation</keyword>
  <keyword>functional capacity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

